CT Innovations invests in cannabis business
Connecticut Innovations recently invested $1.25 million in 1906, a recreational cannabis pills company moving its headquarters to the state. “CI’s investment is a major milestone...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Connecticut Innovations recently invested $1.25 million in 1906, a recreational cannabis pills company moving its headquarters to the state. “CI’s investment is a major milestone...
Sema4 has completed the acquisition of GeneDx. The transaction establishes Sema4 as one of the largest and most advanced providers of genomic testing in the U.S....
Yale University’s Innovation Summit, which has become Yale’s largest entrepreneurship event and the largest gathering of venture capital investors in Connecticut, returns May 17-18 … more BioLabs, a...
The FDA has approved Camzyos™ from Bristol Myers Squibb (mavacamten for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy...
Pfizer says it will acquire New Haven-based Biohaven Pharmaceuticals, known for its migraine drug Nurtec ODT, for $11.6 billion cash. “Pfizer’s capabilities will accelerate our mission to...
View this email in your browser Career News – May 10, 2022 The Career Expo at the Yale Innovation Summit is open to all Summit attendees who...
Cara Therapeutics reports that the European Commission has granted marketing authorization to Kapruvia® (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in...
Yale University has announced its largest ever round of Blavatnik awards: a total of 12 new projects have received over $3 million in accelerator funding. The...
CYduct Diagnostics is focused on transformative products that will enable physicians to intervene at the earliest stages of breast cancer. The company currently develops, produces, and...